المؤلفون: Torrance AW; University of Kansas School of Law, Lawrence, KS, USA.; Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA., de la Fuente-Nunez C; Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cfuente@upenn.edu.; Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA. cfuente@upenn.edu.; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA. cfuente@upenn.edu.; Penn Institute for Computational Science, University of Pennsylvania, Philadelphia, PA, USA. cfuente@upenn.edu.

المصدر: Nature biotechnology [Nat Biotechnol] 2024 Aug; Vol. 42 (8), pp. 1179-1180.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic*/legislation & jurisprudence , Patents as Topic*/ethics, Humans ; Bioethics

المؤلفون: Sherkow JS; College of Law and European Union Center, University of Illinois at Urbana-Champaign, Champaign, Illinois, USA; email: jsherkow@illinois.edu.; Carle Illinois College of Medicine and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.; Center for Advanced Study in Biomedical Innovation Law, Faculty of Law, University of Copenhagen, Copenhagen, Denmark., Cook-Deegan R; School for the Future of Innovation in Society and Consortium for Science, Policy, and Outcomes, Arizona State University, Tempe, Arizona, USA; email: bcd@asu.edu., Greely HT; Law School, Department of Genetics, and Center for Law and the Biosciences, Stanford University, Stanford, California, USA; email: hgreely@stanford.edu.

المصدر: Annual review of genomics and human genetics [Annu Rev Genomics Hum Genet] 2024 Aug; Vol. 25 (1), pp. 397-419. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Annual Reviews Country of Publication: United States NLM ID: 100911346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-293X (Electronic) Linking ISSN: 15278204 NLM ISO Abbreviation: Annu Rev Genomics Hum Genet Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic*, Humans ; United States ; Genetic Testing ; Supreme Court Decisions

المؤلفون: Tu SS; West Virginia University College of Law, Morgantown., Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts., Chao B; University of Denver Sturm College of Law, Denver, Colorado.

المصدر: JAMA [JAMA] 2024 Sep 10; Vol. 332 (10), pp. 837-838.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Drug Industry*/economics , Drug Industry*/legislation & jurisprudence , Patents as Topic*, United States ; Fees, Pharmaceutical/legislation & jurisprudence ; Biosimilar Pharmaceuticals/economics ; Drugs, Generic/economics ; Economic Competition/economics ; Economic Competition/legislation & jurisprudence

المؤلفون: Liu J; School of Intellectual Property, Nanjing University of Science and Technology, Nanjing, Jiangsu, China., Cai W; School of Economics, Zhejiang University of Finance and Economics, Hangzhou, Zhejiang, China.

المصدر: PloS one [PLoS One] 2024 Sep 03; Vol. 19 (9), pp. e0309420. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic*, Carbon/chemistry ; United States ; Digital Technology

المؤلفون: Darrow JJ; Program on Regulation, Therapeutics And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. jonathan.darrow@post.harvard.edu., Van de Wiele V; Program on Regulation, Therapeutics And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Brown B; Program on Regulation, Therapeutics And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Kesselheim AS; Program on Regulation, Therapeutics And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

المصدر: Nature biotechnology [Nat Biotechnol] 2024 Sep; Vol. 42 (9), pp. 1350-1355.

نوع المنشور: Journal Article; Letter

بيانات الدورية: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic*/legislation & jurisprudence , Drug Approval* , Drugs, Generic*/therapeutic use, United States ; Humans ; United States Food and Drug Administration ; Drug Industry/legislation & jurisprudence

المؤلفون: Huang X; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China., Xu S; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China., Duan L; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China., Xu S; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China., Zhu W; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.

المصدر: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 825-842. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic* , Cyclin-Dependent Kinase 4*/antagonists & inhibitors , Cyclin-Dependent Kinase 6*/antagonists & inhibitors , Protein Kinase Inhibitors*/pharmacology , Neoplasms*/drug therapy , Neoplasms*/pathology , Antineoplastic Agents*/pharmacology , Drug Development* , Drug Resistance, Neoplasm*, Humans ; Animals

المؤلفون: Baghel R; Division of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India.; Academy of Scientific and Innovative Research (AcSIR) Ghaziabad, Ghaziabad, India., Chhikara N; Division of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India.; Academy of Scientific and Innovative Research (AcSIR) Ghaziabad, Ghaziabad, India., Kumar P; Division of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India.; Academy of Scientific and Innovative Research (AcSIR) Ghaziabad, Ghaziabad, India., Tamrakar AK; Division of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India.; Academy of Scientific and Innovative Research (AcSIR) Ghaziabad, Ghaziabad, India.

المصدر: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 807-823. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE

مواضيع طبية MeSH: Sodium-Glucose Transporter 2 Inhibitors*/pharmacology , Patents as Topic* , Hypoglycemic Agents*/pharmacology , Drug Development*, Humans ; Animals ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/physiopathology ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/physiopathology

المؤلفون: Zhang C; School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan, P. R. China., Xue ZH; School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan, P. R. China., Luo WH; School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan, P. R. China., Jiang MY; State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, P. R. China., Wu Y; State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, P. R. China.

المصدر: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 759-772. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic* , Drug Development* , Phosphodiesterase Inhibitors*/pharmacology , Cardiovascular Diseases*/drug therapy, Humans ; Animals ; Drug Design ; Nervous System Diseases/drug therapy ; 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors ; 3',5'-Cyclic-AMP Phosphodiesterases/metabolism ; Neurodegenerative Diseases/drug therapy ; Neurodegenerative Diseases/physiopathology

المؤلفون: Mahboubi-Rabbani M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Abdolghaffari AH; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Ghesmati M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Amini A; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zarghi A; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

المصدر: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 733-757. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE

مواضيع طبية MeSH: Patents as Topic* , Cyclooxygenase 2 Inhibitors*/pharmacology , Antineoplastic Agents*/pharmacology , Neoplasms*/drug therapy , Neoplasms*/enzymology , Drug Development* , Cyclooxygenase 2*/metabolism , Cyclooxygenase 2*/drug effects, Humans ; Animals ; Structure-Activity Relationship ; Dinoprostone/metabolism ; Drug Design

المؤلفون: Kirshner G; NZa, Utrecht, The Netherlands., Makai P; Erasmus University Rotterdam, Rotterdam, The Netherlands.; ACM, P.O. Box 16326, 2500 BH, The Hague, The Netherlands., Brouns C; Zorgverzekeraars Nederland, Zeist, The Netherlands., Timmers L; National Healthcare Institute, Diemen, The Netherlands., Kemp R; Erasmus University Rotterdam, Rotterdam, The Netherlands. ron.kemp@acm.nl.; ACM, P.O. Box 16326, 2500 BH, The Hague, The Netherlands. ron.kemp@acm.nl.

المصدر: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Sep; Vol. 25 (7), pp. 1147-1163. Date of Electronic Publication: 2024 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE

مواضيع طبية MeSH: Trastuzumab*/economics , Trastuzumab*/therapeutic use , Biosimilar Pharmaceuticals*/economics , Patents as Topic*, Humans ; Netherlands ; Female ; Breast Neoplasms/drug therapy ; Health Care Costs/statistics & numerical data ; Antineoplastic Agents, Immunological/economics ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/administration & dosage ; Injections, Subcutaneous ; Middle Aged